Ledong Wan

Dr. Ledong Wan

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2023 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
LWLedong Wan
Ledong Wan
KLKuang-Ting Lin
Kuang-Ting Lin
MRMohammad Rahman
Mohammad Rahman
YIYuma Ishigami
Yuma Ishigami
ZWZhikai Wang
Zhikai Wang
AKAdrian R. Krainer
Adrian R. Krainer
Inflammation is strongly associated with pancreatic ductal adenocarcinoma (PDAC), a highly lethal malignancy. Dysregulated RNA splicing factors have been widely reported in tumorigenesis, but their involvement in pancreatitis and PDAC is not well understood. Here, we report that the splicing factor SRSF1 is highly expressed in pancreatitis, PDAC precursor lesions, and tumors. Increased SRSF1 is sufficient to induce pancreatitis and accelerate KRASG12D-mediated PDAC. Mechanistically, SRSF1 activates MAPK signaling—partly by upregulating interleukin 1 receptor type 1 (IL1R1) through alternative-splicing-regulated mRNA stability. Additionally, SRSF1 protein is destabilized through a negative feedback mechanism in phenotypically normal epithelial cells expressing KRASG12D in mouse pancreas and in pancreas organoids acutely expressing KRASG12D, buffering MAPK signaling and maintaining pancreas cell homeostasis. This negative feedback regulation of SRSF1 is overcome by hyperactive MYC, facilitating PDAC tumorigenesis. Our findings implicate SRSF1 in the etiology of pancreatitis and PDAC, and point to SRSF1-misregulated alternative splicing as a potential therapeutic target. Significance: We describe the regulation of splicing factor SRSF1 expression in the context of pancreas cell identity, plasticity, and inflammation. SRSF1 protein downregulation is involved in a negative feedback cellular response to KRASG12D expression, contributing to pancreas cell homeostasis. Conversely, upregulated SRSF1 promotes pancreatitis and accelerates KRASG12D-mediated tumorigenesis through enhanced IL1 and MAPK signaling. This article is highlighted in the In This Issue feature, p. 1501

16 September 2022 in Genes
Verified
Journal Article
Open access
PDF file
LWLedong Wan
Ledong Wan
MDMin Deng
Min Deng
HZHonghe Zhang
Honghe Zhang
Substantial emerging evidence supports that dysregulated RNA metabolism is associated with tumor initiation and development. Serine/Arginine-Rich proteins (SR) are a number of ultraconserved and structurally related proteins that contain a characteristic RS domain rich in arginine and serine residues. SR proteins perform a critical role in spliceosome assembling and conformational transformation, contributing to precise alternative RNA splicing. Moreover, SR proteins have been reported to participate in multiple other RNA-processing-related mechanisms than RNA splicing, such as genome stability, RNA export, and translation. The dysregulation of SR proteins has been reported to contribute to tumorigenesis through multiple mechanisms. Here we reviewed the different biological roles of SR proteins and strategies for functional rectification of SR proteins that may serve as potential therapeutic approaches for cancer.

17 June 2024 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
DMDiogo Maia-Silva
Diogo Maia-Silva
PCPatrick J. Cunniff
Patrick J. Cunniff
ASAllison C. Schier
Allison C. Schier
DSDamianos Skopelitis
Damianos Skopelitis
MTMarygrace C. Trousdell
Marygrace C. Trousdell
CVChristopher R. Vakoc
Christopher R. Vakoc

23 June 2023
Verified
Other
Open access
LWLedong Wan
Ledong Wan
KLKuan-Ting Lin
Kuan-Ting Lin
MRMohammad Rahman
Mohammad Rahman
YIYuma Ishigami
Yuma Ishigami
ZWZhikai Wang
Zhikai Wang
AKAdrian R. Krainer
Adrian R. Krainer
Inflammation is strongly associated with pancreatic ductal adenocarcinoma (PDAC), a highly lethal malignancy. Dysregulated RNA splicing factors have been widely reported in tumorigenesis, but their involvement in pancreatitis and PDAC is not well understood. Here, we report that the splicing factor SRSF1 is highly expressed in pancreatitis, PDAC precursor lesions, and tumors. Increased SRSF1 is sufficient to induce pancreatitis and accelerate KRASG12D-mediated PDAC. Mechanistically, SRSF1 activates MAPK signaling—partly by upregulating interleukin 1 receptor type 1 (IL1R1) through alternative-splicing-regulated mRNA stability. Additionally, SRSF1 protein is destabilized through a negative feedback mechanism in phenotypically normal epithelial cells expressing KRASG12D in mouse pancreas and in pancreas organoids acutely expressing KRASG12D, buffering MAPK signaling and maintaining pancreas cell homeostasis. This negative feedback regulation of SRSF1 is overcome by hyperactive MYC, facilitating PDAC tumorigenesis. Our findings implicate SRSF1 in the etiology of pancreatitis and PDAC, and point to SRSF1-misregulated alternative splicing as a potential therapeutic target.Significance:We describe the regulation of splicing factor SRSF1 expression in the context of pancreas cell identity, plasticity, and inflammation. SRSF1 protein downregulation is involved in a negative feedback cellular response to KRASG12D expression, contributing to pancreas cell homeostasis. Conversely, upregulated SRSF1 promotes pancreatitis and accelerates KRASG12D-mediated tumorigenesis through enhanced IL1 and MAPK signaling.

29 October 2023 in Genes
Verified
Journal Article
Open access
PDF file
RIRafikul Islam
Rafikul Islam
PNPreeti Nagar
Preeti Nagar
SNShegufta Tasneem Neetole
Shegufta Tasneem Neetole
LWLedong Wan
Ledong Wan
MRMohammad Rahman
Mohammad Rahman
Since the discovery of RNA splicing as a fundamental step to remove introns from pre-mRNA to produce mature mRNAs, substantial research in the past decades has highlighted RNA splicing as a critical mediator of gene expression and proteome diversity, also being important in many developmental and biological processes

4 June 2026 in Biochemical Society Transactions
Verified
Journal Article
Open access
XZXin Zhang
Xin Zhang
CLChristopher Luo
Christopher Luo
KCKevin Coughlin
Kevin Coughlin
FLFeng-Qian Li
Feng-Qian Li
KTKen-Ichi Takemaru
Ken-Ichi Takemaru
LWLedong Wan
Ledong Wan
Pancreatic acinar cells are highly specialized secretory epithelial cells in which coordinated transcriptional, epigenetic, and post-transcriptional regulatory mechanisms maintain digestive enzyme production, polarized architecture, and lineage fidelity. This homeostatic network preserves acinar identity while enabling rapid adaptation to physiological stress. Disruption of these regulatory mechanisms triggers acinar-to-ductal metaplasia (ADM), a reversible reprogramming state that supports acinar cell survival and regeneration after acute injury. However, if ADM persists under chronic inflammation or oncogenic KRAS activation, it can facilitate the initiation of pancreatic ductal adenocarcinoma. Elucidating these mechanisms offers opportunities to restore acinar cell homeostasis, reverse ADM, and prevent neoplastic transformation. In this review, we summarize current knowledge on the transcriptional, epigenetic, and post-transcriptional regulation of acinar cell homeostasis and plasticity, with emphasis on their roles in ADM.